CCL3 derived from esophageal squamous cell carcinoma (ESCC) cells and TAMs binds to CCR5, activating Akt and ERK pathways to promote ESCC cell invasion and migration [89]. Here, CCR5 is linked to esophageal squamous cell carcinoma.